Your browser doesn't support javascript.
loading
RCM macrocyclization made practical: an efficient synthesis of HCV protease inhibitor BILN 2061.
Shu, Chutian; Zeng, Xingzhong; Hao, Ming-Hong; Wei, Xudong; Yee, Nathan K; Busacca, Carl A; Han, Zhengxu; Farina, Vittorio; Senanayake, Chris H.
Afiliação
  • Shu C; Department of Chemical Development, Boehringer Ingelheim Pharmaceuticals, 900 Ridgebury Road, Ridgefield Connecticut 06877, USA. chutian.shu@boehringer-ingelheim.com
Org Lett ; 10(6): 1303-6, 2008 Mar 20.
Article em En | MEDLINE | ID: mdl-18293994
ABSTRACT
We report here that dramatic improvement of the key RCM reaction in the synthesis of HCV protease inhibitor BILN2061 can be achieved by N-substitution of the diene substrate with an electron-withdrawing group. Mechanistic studies using 1H NMR spectroscopy showed an unprecedented switch of the initiation sites and the correlation between such switch and the results of RCM, from the unmodified to the modified substrates. We also provided theoretical evidence that such modification may also increase the thermodynamic preference of the macrocyclic product over the diene substrate.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Proteases / Quinolinas / Tiazóis / Carbamatos / Hepacivirus / Compostos Macrocíclicos Idioma: En Ano de publicação: 2008 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Proteases / Quinolinas / Tiazóis / Carbamatos / Hepacivirus / Compostos Macrocíclicos Idioma: En Ano de publicação: 2008 Tipo de documento: Article